Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine

      Clinical Trials
      Novavax, Inc., a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced that the first volunteers have been enrolled in the...

      CPI Expands Continuous Manufacturing Partner Network

      Drug Development
      CPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines...

      Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic

      Drug Development
      Q BioMed Inc., a commercial-stage biotech company, said that with its technology partner, Mannin Research, a GMP production contract has been initiated for MAN-19,...

      Daiichi Sankyo and AstraZeneca Enter New Global Development and Commercialization Collaboration for Daiichi Sankyo’s ADC DS-1062

      Drug Development
      Daiichi Sankyo Company announced that it has entered into a global development and commercialization agreement with AstraZeneca for Daiichi Sankyo’s DS-1062, a TROP2 directed...

      Gileads Kite bags second CAR-T okay with Tecartus nod in mantle cell lymphoma

      FDA Approvals
      Kite, a Gilead Company announced that the U.S. FDA has granted accelerated approval to Tecartus™ (brexucabtagene autoleucel, formerly KTE-X19), the first and only approved...

      Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19

      Clinical Trials
      Glenmark Pharmaceuticals Ltd. a global research-led pharmaceutical company announced top-line results from a Phase 3 clinical trial in mild to moderate COVID-19 patients conducted...

      US doubles COVID vaccine fund as Moderna enters final phase of clinical trial

      Clinical Trials
      The United States has doubled its investment to nearly $1 billion to expedite development of a potential COVID-19 vaccine by American firm Moderna, which...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.